Our Services
Medical Information
Helpful Resources
Published on: 9/16/2026
Alopecia areata can sometimes progress beyond patchy hair loss to affect the entire scalp (alopecia totalis) or all body hair (alopecia universalis), though most people experience limited patches that may regrow, and the risk depends on factors like age at onset, extent of loss, nail changes, and family history. Because it is an autoimmune condition, it can also occur alongside thyroid disease, vitiligo, atopic dermatitis, type 1 diabetes, or anemia, so widespread or unusual shedding sometimes points to another underlying issue worth evaluating. Other causes of diffuse hair loss, including telogen effluvium, scarring alopecias, and nutritional deficiencies, can mimic or overlap with it. There are several important details that influence whether your hair loss is likely to spread and which tests may be needed, so see below to understand more.
Since patterns of hair loss can look similar but require very different treatment, and because early intervention often gives the best chance of regrowth, it helps to get an organized picture of your symptoms before your next appointment. A free, instant, online symptom check can help you sort out which clues in your own case matter most, what conditions may be worth ruling out, and which type of clinician to see next.
Last reviewed for medical accuracy: 09/15/2026
Could Alopecia Areata Spread to All My Hair or Is It a Sign of Another Disease?
Alopecia areata is a common autoimmune condition that causes patchy hair loss. It affects up to 2% of people at some point in their lives. If you’ve noticed one or more bald spots, it’s natural to worry whether those patches might spread to cover your entire scalp—or even your body—and whether there’s a more serious underlying disease.
Below, you’ll find clear, evidence-based information about:
Alopecia areata occurs when your immune system mistakenly attacks hair follicles, causing them to enter a resting phase. Hair shafts then fall out, typically in small, round patches. In most cases:
Key points:
Yes, alopecia areata can progress in severity but in variable ways:
Patchy Alopecia Areata
Alopecia Totalis
Alopecia Universalis
Progression is unpredictable:
Bottom line:
While any progression can feel alarming, severe forms remain relatively uncommon. Regular follow-up with a dermatologist helps monitor changes and adapt treatment early.
Alopecia areata itself is a distinct autoimmune condition. However, it can coexist with other autoimmune disorders in some individuals. Having alopecia areata does not necessarily mean you have—or will develop—another disease, but you may have a slightly higher risk of:
When to consider further evaluation:
Even though most cases of alopecia areata follow a benign course, certain signs warrant a prompt check-in with your healthcare provider:
You might also consider a free, online symptom check, using the doctor approved Ubie Symptom Checker to help clarify whether you need to pursue lab tests or specialist referrals.
A dermatologist will typically diagnose alopecia areata based on:
There’s no one-size-fits-all cure, but several treatments can help stimulate hair regrowth and limit new loss. Your dermatologist will tailor therapy to the extent of your disease, age, and personal preferences. Common approaches:
Topical Corticosteroids
Applied directly to patches to reduce inflammation.
Intralesional Corticosteroid Injections
Small steroid injections into each bald patch, often effective for limited disease.
Topical Immunotherapy
Applying agents (e.g., diphenylcyclopropenone) to provoke a mild allergic reaction that distracts the immune system.
Minoxidil (Rogaine®)
A topical medication that can stimulate hair follicles.
Oral Treatments
In more extensive disease, low-dose corticosteroids or medications that suppress the immune system.
Janus Kinase (JAK) Inhibitors
Newer oral drugs (e.g., tofacitinib, ruxolitinib) showing promising results for severe cases. These require careful monitoring for side effects.
Supportive Options
Wigs, scarves, cosmetic camouflage, eyebrow microblading, and counseling for emotional support.
Strategies to feel more in control:
If you’re ever unsure about your symptoms or worried about other health issues, speak with your doctor. For a quick preliminary evaluation, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. It’s a convenient way to gather information before your appointment.
Important: This information is intended to be comprehensive yet accessible. It does not replace medical advice. If you experience life-threatening symptoms or severe emotional distress, please seek immediate medical attention. Always speak to your doctor about any serious or persistent health concerns.
(References)
* Strazzulla LC, Wang EHC, Avila L, Lo Sicco K, Brinster N, Christiano AM, Shapiro J. Alopecia areata: Disease characteristics, clinical evaluation, and new perspectives on pathogenesis. J Am Acad Dermatol. 2018 Jan;78(1):1-12. doi: 10.1016/j.jaad.2017.04.1141. PMID: 29241771.
* Lee HH, Gwillim E, Patel KR, Hua T, Rastogi S, Ibler E, Silverberg JI. Epidemiology of alopecia areata, ophiasis, totalis, and universalis: A systematic review and meta-analysis. J Am Acad Dermatol. 2020 Mar;82(3):675-682. doi: 10.1016/j.jaad.2019.08.032. Epub 2019 Aug 19. PMID: 31437543.
* Conic RZ, Tamashunas NL, Damiani G, Fabbrocini G, Cantelli M, Young Dermatologists Italian Network, Bergfeld WF. Comorbidities in pediatric alopecia areata. J Eur Acad Dermatol Venereol. 2020 Dec;34(12):2898-2901. doi: 10.1111/jdv.16727. Epub 2020 Aug 6. PMID: 32531131.
* Toussi A, Barton VR, Le ST, Agbai ON, Kiuru M. Psychosocial and psychiatric comorbidities and health-related quality of life in alopecia areata: A systematic review. J Am Acad Dermatol. 2021 Jul;85(1):162-175. doi: 10.1016/j.jaad.2020.06.047. Epub 2020 Jun 17. PMID: 32561373; PMCID: PMC8260215.
* Sterkens A, Lambert J, Bervoets A. Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options. Clin Exp Med. 2021 May;21(2):215-230. doi: 10.1007/s10238-020-00673-w. Epub 2021 Jan 1. PMID: 33386567.
* Zhou C, Li X, Wang C, Zhang J. Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management. Clin Rev Allergy Immunol. 2021 Dec;61(3):403-423. doi: 10.1007/s12016-021-08883-0. Epub 2021 Aug 17. PMID: 34403083.
* King BA, Craiglow BG. Janus kinase inhibitors for alopecia areata. J Am Acad Dermatol. 2023 Aug;89(2S):S29-S32. doi: 10.1016/j.jaad.2023.05.049. PMID: 37591562.
* Dainichi T, Iwata M, Kaku Y. Alopecia areata: What's new in the epidemiology, comorbidities, and pathogenesis? J Dermatol Sci. 2023 Dec;112(3):120-127. doi: 10.1016/j.jdermsci.2023.09.008. Epub 2023 Oct 11. PMID: 37833164.
* Rudnicka L, Arenbergerova M, Grimalt R, Ioannides D, Katoulis AC, Lazaridou E, Olszewska M, Ovcharenko YS, Piraccini BM, Prohic A, Rakowska A, Reygagne P, Richard MA, Soares RO, Starace M, Vañó-Galvan S, Waskiel-Burnat A. European expert consensus statement on the systemic treatment of alopecia areata. J Eur Acad Dermatol Venereol. 2024 Apr;38(4):687-694. doi: 10.1111/jdv.19768. Epub 2024 Jan 2. PMID: 38169088.
* Kalil L, Welch D, Heath CR, Craiglow BG. Systemic Therapies for Pediatric Alopecia Areata. Pediatr Dermatol. 2025 Mar;42 Suppl 1:36-42. doi: 10.1111/pde.15822. PMID: 40044621.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.